Verition Fund Management
MRNS

Verition Fund Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Verition Fund Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,522
Closed -$24K – 3609
2024
Q2 		$24K Buy
+20,522
New +$51.3K ﹤0.01% 2856
2023
Q2 		– Sell
-47,108
Closed -$325K – 2651
2023
Q1 		$325K Buy
+47,108
New +$295K ﹤0.01% 1471
2021
Q3 		– Sell
-72,025
Closed -$1.29M – 2395
2021
Q2 		$1.29M Buy
+72,025
New +$1.16M 0.01% 692
2018
Q2 		– Sell
-3,560
Closed -$54K – 1388
2018
Q1 		$54K Buy
+3,560
New +$84.8K ﹤0.01% 1072

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Verition Fund Management's MRNS Position: Q3 2024 in Review

Verition Fund Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2024, closing a stake of 20,522 shares — an estimated $24K sold.

Verition Fund Management first reported a position in MRNS in Q1 2018 and held it in 4 quarters. The position peaked at $1.29M in Q2 2021. 75 funds tracked by Wall St. Rank hold MRNS as of Q3 2024.

  • Verition Fund Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 20,522 Marinus Pharmaceuticals, Inc shares in Q3 2024, an estimated $24K.
  • Verition Fund Management first reported a position in Marinus Pharmaceuticals, Inc in Q1 2018 and held it in 4 quarters.
  • Verition Fund Management's Marinus Pharmaceuticals, Inc position peaked at $1.29M in Q2 2021.
  • 75 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.